Skip to main content
Log in

Carcinogenicity of tetraethyl lead

  • Specialia
  • Pharmacologica
  • Published:
Experientia Aims and scope Submit manuscript

Zusammenfassung

Ein vermehrtes Vorkommen von Lymphomas zeigte sich bei mit Tetraäthylblei behandelten weiblichen Mäusen (12%) im Gegensatz zu den entsprechenden Kontrollen (0%). Die carcinogene Wirkung von Tetraäthylblei wurde durch parenterale Administration einer totalen Dosis von 0.6 mg an neugeborenen Schweizer Mäusen gezeigt.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. F. Springman, E. Bingham andK. Stemmer, A.M.A. Archs Environ. Health6, 469 (1963).

    Article  CAS  Google Scholar 

  2. J. E. Cremer, Occup. Hlth Rev.17, 14 (1965).

    CAS  Google Scholar 

  3. S. S. Epstein, S. Joshi, J. Andrea, N. Mantel, E. Sawicki, T. Stanley andE. C. Tabor, Nature212, 1305 (1966).

    Article  CAS  Google Scholar 

  4. S. S. Epstein, J. Andrea, S. Joshi andN. Mantel, Cancer Res.27, 1900 (1967).

    CAS  Google Scholar 

  5. H. V. Zollinger, Virchows Arch. Path. Anat. Physiol.323, 694 (1954).

    Article  Google Scholar 

  6. G. J. Van Esch, H. Van Genderen andH. H. Vink, Br. J. Cancer16, 289 (1962).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Supported by Grant No. C-6516 from the National Cancer Institute, USPHS.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Epstein, S.S., Mantel, N. Carcinogenicity of tetraethyl lead. Experientia 24, 580–581 (1968). https://doi.org/10.1007/BF02153784

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02153784

Keywords

Navigation